Foot and Heel reconstruction using Reverse Sural Fascio cutaneous flaps after Melanoma Resection
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 7, Pages 976-982
AbstractMelanoma is the most common malignant neoplasm of the foot and ankle and are associated with a poor prognosis. The aim of the current study was to evaluate the functional and oncological outcomes of salvage surgery using Fascio- cutaneous flaps for soft tissue reconstruction of the foot following the resection of a melanoma. A retrospective review was conducted to evaluate patients who presented with foot melanoma and underwent salvage surgery and defect reconstruction using Fascio- cutaneous flap between January 2015 and December 2021at Acharya Tulsi Regional cancer Treatment & Research institute, Bikaner. The postoperative morbidity, surgical complications, functional outcomes and oncological outcomes were evaluated. 10 patients were enrolled. The median follow‑up time of the patients was 52 months (range, 8‑84 months). A reverse sural fasciocutaneous island flap was used in all patients to perform the foot reconstruction. All 10 cutaneous flaps survived and provided satisfactory coverage. Only one cutaneous flap showed partial necrosis and required treatment comprising of debridement and regular changes to the wound dressing. The overall survival rate of patients was 69.0% and good oncological outcomes. Salvage surgery with Fasciocutaneous flap reconstruction was found to be a reliable option for patients presenting with malignant melanoma of the foot.
- Article View: 30
- PDF Download: 79